Shortage of Fluoxetine (Medreich) 10 mg capsule

1 Feb 2024

Policy

Fluoxetine (Medreich ®) for the treatment of major depressive disorders and obsessive-compulsive disorder is now listed on the Pharmaceutical Benefits Scheme (PBS) for the current supply shortage under Section 19A.

For more information on Fluoxetine (Medreich ®), please contact the PBS directly.

More news & views

28 May 2024

PPG 14: National Codes and Standards has been rescinded

The College’s Professional Practice Guideline 14: National Codes and Standards has been rescinded.

27 May 2024

Interview recruitment for study on long-term psychodynamic psychotherapy

Share your experience of long-term psychodynamic psychotherapy treatment for mood disorders.

17 May 2024

Updated College guidance on the administration of rTMS

The Professional Practice Guideline on repetitive Transcranial Magnetic Stimulation (rTMS) reflects ...